Nawata Kazumitsu
Hitotsubashi Institute for Advanced Study (HISA), Hitotsubashi University, Kunitachi, Japan.
Front Cardiovasc Med. 2023 Jun 2;10:1103250. doi: 10.3389/fcvm.2023.1103250. eCollection 2023.
Heart disease (HD), cerebrovascular disease (CBD), and kidney disease (KD) are serious diseases worldwide. These diseases constitute the leading causes of death worldwide and are costly to treat. An analysis of risk factors is necessary to prevent these diseases.
Risk factors were analyzed using data from 2,837,334, 2,864,874, and 2,870,262 medical checkups obtained from the JMDC Claims Database. The side effects of medications used to control hypertension (antihypertensive medications), hyperglycemia (antihyperglycemic medications), and hypercholesterolemia (cholesterol medications), including their interactions, were also evaluated. Logit models were used to calculate the odds ratios and confidence intervals. The sample period was from January 2005 to September 2019.
Age and history of diseases were found to be very important factors, and the risk of having diseases could be almost doubled. Urine protein levels and recent large weight changes were also important factors for all three diseases and made the risks 10%-30% higher, except for KD. For KD, the risk was more than double for individuals with high urine protein levels. Negative side effects were observed with antihypertensive, antihyperglycemic, and cholesterol medications. In particular, when antihypertensive medications were used, the risks were almost doubled for HD and CBD. The risk would be triple for KD when individuals were taking antihypertensive medications. If they did not take antihypertensive medications and took other medications, these values were lower (20%-40% for HD, 50%-70% for CBD, and 60%-90% for KD). The interactions between the different types of medications were not very large. When antihypertensive and cholesterol medications were used simultaneously, the risk increased significantly in cases of HD and KD.
It is very important for individuals with risk factors to improve their physical condition for the prevention of these diseases. Taking antihypertensive, antihyperglycemic, and cholesterol medications, especially antihypertensive medications, may be serious risk factors. Special care and additional studies are necessary to prescribe these medications, particularly antihypertensive medications.
No experimental interventions were performed. As the dataset was comprised of the results of health checkups of workers in Japan, individuals aged 76 and above were not included. Since the dataset only contained information obtained in Japan and the Japanese are ethnically homogeneous, potential ethnic effects on the diseases were not evaluated.
心脏病(HD)、脑血管疾病(CBD)和肾脏疾病(KD)是全球范围内的严重疾病。这些疾病是全球主要死因,治疗成本高昂。有必要对风险因素进行分析以预防这些疾病。
使用从JMDC理赔数据库获取的2837334例、2864874例和2870262例体检数据对风险因素进行分析。还评估了用于控制高血压(抗高血压药物)、高血糖(抗高血糖药物)和高胆固醇血症(胆固醇药物)的药物的副作用,包括它们之间的相互作用。使用逻辑模型计算比值比和置信区间。样本期为2005年1月至2019年9月。
发现年龄和疾病史是非常重要的因素,患病风险可能几乎翻倍。尿蛋白水平和近期体重大幅变化也是这三种疾病的重要因素,除KD外,会使风险提高10%-30%。对于KD,尿蛋白水平高的个体风险增加一倍以上。观察到抗高血压药、抗高血糖药和胆固醇药物有负面副作用。特别是使用抗高血压药物时,HD和CBD的风险几乎翻倍。服用抗高血压药物时,KD的风险将增加两倍。如果他们不服用抗高血压药物而服用其他药物,这些数值会更低(HD为20%-40%,CBD为50%-70%,KD为60%-90%)。不同类型药物之间的相互作用不是很大。同时使用抗高血压药和胆固醇药物时,HD和KD病例的风险显著增加。
对于有风险因素的个体,改善身体状况以预防这些疾病非常重要。服用抗高血压药、抗高血糖药和胆固醇药物,尤其是抗高血压药物,可能是严重的风险因素。开这些药物,尤其是抗高血压药物时,需要特别小心并进行更多研究。
未进行实验性干预。由于数据集由日本工人的健康检查结果组成,未包括76岁及以上的个体。由于数据集仅包含在日本获得的信息,且日本人种族单一,未评估潜在的种族对疾病的影响。